WO2001070203A3 - Agent de traitement de l'hepatite c - Google Patents

Agent de traitement de l'hepatite c Download PDF

Info

Publication number
WO2001070203A3
WO2001070203A3 PCT/AT2001/000076 AT0100076W WO0170203A3 WO 2001070203 A3 WO2001070203 A3 WO 2001070203A3 AT 0100076 W AT0100076 W AT 0100076W WO 0170203 A3 WO0170203 A3 WO 0170203A3
Authority
WO
WIPO (PCT)
Prior art keywords
ukrain
agent
treating hepatitis
hepatitis
treating
Prior art date
Application number
PCT/AT2001/000076
Other languages
German (de)
English (en)
Other versions
WO2001070203A2 (fr
Inventor
Wassyl Nowicky
Original Assignee
Nowicky Wassili
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EA200200584A priority Critical patent/EA200200584A1/ru
Priority to JP2001568401A priority patent/JP2003527414A/ja
Priority to MXPA02004993A priority patent/MXPA02004993A/es
Priority to IL14931401A priority patent/IL149314A0/xx
Application filed by Nowicky Wassili filed Critical Nowicky Wassili
Priority to KR1020027005739A priority patent/KR20020087045A/ko
Priority to PL01365000A priority patent/PL365000A1/xx
Priority to BR0107211-0A priority patent/BR0107211A/pt
Priority to CA002389173A priority patent/CA2389173A1/fr
Priority to AU2001239000A priority patent/AU2001239000A1/en
Publication of WO2001070203A2 publication Critical patent/WO2001070203A2/fr
Priority to IS6360A priority patent/IS6360A/is
Priority to HR20020367A priority patent/HRP20020367A2/hr
Priority to NO20022253A priority patent/NO20022253D0/no
Publication of WO2001070203A3 publication Critical patent/WO2001070203A3/fr
Priority to BG107088A priority patent/BG107088A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne l'utilisation du produit de conversion des alcaloïdes de Chelidonium majus L. avec de la triaziridide de l'acide thiophosphorique pour produire un médicament destiné au traitement de l'hépatite C.
PCT/AT2001/000076 2000-03-22 2001-03-20 Agent de traitement de l'hepatite c WO2001070203A2 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
PL01365000A PL365000A1 (en) 2000-03-22 2001-03-20 Agent for treating hepatitis c containing ukrain
MXPA02004993A MXPA02004993A (es) 2000-03-22 2001-03-20 Medicamento para el tratramiento de hepatitis c.
IL14931401A IL149314A0 (en) 2000-03-22 2001-03-20 Agent for treating hepatitis c
CA002389173A CA2389173A1 (fr) 2000-03-22 2001-03-20 Agent de traitement de l'hepatite c
KR1020027005739A KR20020087045A (ko) 2000-03-22 2001-03-20 Ｃ형 간염 치료제
JP2001568401A JP2003527414A (ja) 2000-03-22 2001-03-20 Ｃ型肝炎を治療するための薬剤
BR0107211-0A BR0107211A (pt) 2000-03-22 2001-03-20 Agente para tratar hepatite c
EA200200584A EA200200584A1 (ru) 2000-03-22 2001-03-20 Средство для лечения гепатита c
AU2001239000A AU2001239000A1 (en) 2000-03-22 2001-03-20 Agent for treating hepatitis C containing Ukrain
IS6360A IS6360A (is) 2000-03-22 2002-04-24 Lyf til meðhöndlunar á lifrarbólgu C
HR20020367A HRP20020367A2 (en) 2000-03-22 2002-04-26 Agent for treating hepatitis c
NO20022253A NO20022253D0 (no) 2000-03-22 2002-05-10 Middel til behandling av hepatitt C
BG107088A BG107088A (en) 2000-03-22 2002-09-12 Agent for treating hepatitis c

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ATA481/2000 2000-03-22
AT0048100A AT408719B (de) 2000-03-22 2000-03-22 Mittel zur behandlung von hepatitis c

Publications (2)

Publication Number Publication Date
WO2001070203A2 WO2001070203A2 (fr) 2001-09-27
WO2001070203A3 true WO2001070203A3 (fr) 2002-09-06

Family

ID=3674939

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AT2001/000076 WO2001070203A2 (fr) 2000-03-22 2001-03-20 Agent de traitement de l'hepatite c

Country Status (17)

Country Link
JP (1) JP2003527414A (fr)
KR (1) KR20020087045A (fr)
CN (1) CN1416347A (fr)
AT (1) AT408719B (fr)
AU (1) AU2001239000A1 (fr)
BG (1) BG107088A (fr)
BR (1) BR0107211A (fr)
CA (1) CA2389173A1 (fr)
EA (1) EA200200584A1 (fr)
HR (1) HRP20020367A2 (fr)
IL (1) IL149314A0 (fr)
IS (1) IS6360A (fr)
MA (1) MA25509A1 (fr)
MX (1) MXPA02004993A (fr)
NO (1) NO20022253D0 (fr)
PL (1) PL365000A1 (fr)
WO (1) WO2001070203A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH695417A5 (de) * 2001-11-15 2006-05-15 Ddr Wassyl Nowicky Dipl Ing Verfahren zur Umsetzung von Alkaloiden.
EP1459753A1 (fr) 2003-03-18 2004-09-22 Nowicky, Wassyl, Dipl.-Ing. DDr. Dérivés quaternaires de chelidonine et d'alkaloides, procédé pour leur préparation et leur utilisation dans la préparation de médicaments
EP2083825A4 (fr) * 2006-09-26 2009-11-04 Addiction Res Inst Inc Compositions de traitement de l'hépatite c et procédés d'utilisation des compositions de traitement de l'hépatite c
CN106343303A (zh) * 2015-07-13 2017-01-25 张如安 灭杀乙肝病毒的饮料
CN106109538A (zh) * 2016-07-29 2016-11-16 桂林淮安天然保健品开发有限公司 治疗丙肝的药物组合物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0393575A1 (fr) * 1989-04-17 1990-10-24 G.D. Searle & Co. Composition pour le traitement de néoplasia contenant un agent antinéoplastique et un agent protecteur réduisant les effets secondaires

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3128018A1 (de) * 1981-07-13 1983-04-07 Wassyl 1060 Wien Nowicky "verfahren zum diagnostizieren und fuer die therapeutische behandlung von tumoren und/oder infektioesen krankheiten verschiedenster art unter praeparativem einsatz von alkaloid-verbindungen bzw. deren salze"
US4970212A (en) * 1982-05-18 1990-11-13 Nowicky Wassili Method of treating human illnesses which compromise the ability to mount an effective immunological response
US4816462A (en) * 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0393575A1 (fr) * 1989-04-17 1990-10-24 G.D. Searle & Co. Composition pour le traitement de néoplasia contenant un agent antinéoplastique et un agent protecteur réduisant les effets secondaires

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
I. VOLTCHEK, T. SOLOGUB ET AL.: "Choice for ukrain and interferon-alpha doses for the cancer patients therapy", EJC, vol. 35, no. 5, October 1999 (1999-10-01), pages s20, XP002197747 *

Also Published As

Publication number Publication date
NO20022253L (no) 2002-05-10
IL149314A0 (en) 2002-11-10
BR0107211A (pt) 2004-01-06
NO20022253D0 (no) 2002-05-10
CN1416347A (zh) 2003-05-07
PL365000A1 (en) 2004-12-27
HRP20020367A2 (en) 2004-02-29
AT408719B (de) 2002-02-25
BG107088A (en) 2003-05-30
EA200200584A1 (ru) 2003-06-26
JP2003527414A (ja) 2003-09-16
MA25509A1 (fr) 2002-07-01
KR20020087045A (ko) 2002-11-21
MXPA02004993A (es) 2003-10-14
CA2389173A1 (fr) 2001-09-27
IS6360A (is) 2002-04-24
ATA4812000A (de) 2001-07-15
AU2001239000A1 (en) 2001-10-03
WO2001070203A2 (fr) 2001-09-27

Similar Documents

Publication Publication Date Title
IL145178A0 (en) A process for the preparation of olefinic epothilones
AU632604B2 (en) A process for the catalytic decomposition of chlorofluoro- alkanes
AU7466900A (en) A process for the preparation of h-tyr-d-ala-phe(f)-phe-nh2
AU5446699A (en) Process for the production of bisphenol a
WO2001070203A3 (fr) Agent de traitement de l'hepatite c
AU5687090A (en) Process for the manufacture of a poly-l-olefin
IL142793A0 (en) Process for the production of a shaped article
AU2038988A (en) A process for the manufacture of novel unsaturated amino acid compounds
MXPA02006674A (es) Proceso novedoso para la preparacion de alfa-(2,4-disulfofenil)-n-ter-butilnitrona y las sales farmaceuticamente aceptables de la misma.
HUP9903478A3 (en) New process for the production of a salt of clavulanic acid
HUP0300869A3 (en) Process for the purification of a salt of clavulanic acid
HUT72040A (en) Process for the manufacture of aminomethanephosphonic acid
EP0374410A3 (fr) Acide 2-azabicyclo(2.2.1)hept-5-ène-2-acétique, dérivés de celui-ci et composés apparentés, procédé pour la préparation de ces composés et l'utilisation de ces composés pour la préparation de N-phosphonométhylglycine
NO20014051D0 (no) Fremgangsmate for fremstilling av et noringsmiddel
FI904117A0 (fi) Foerfarande foer framstaellning av alkoxialkylidenmalonsyraestrar.
EP0928814A3 (fr) Procédé de fabrication de composés de dioxazine
HU9502302D0 (en) Process for preparation of 2-cyanimino-thiazolidine
SG47712A1 (en) Process for the preparation of 2,4,5-tribromopyrrole-3-carbonitrile
HUP0003621A3 (en) A process for the preparation of metal salts of clavulanic acid
AU7285896A (en) A process for the preparation of alpha-chloromethylphenylacetic acid derivatives
IL124177A0 (en) A process for the production of distyryl-biphenyl compounds
IL120963A (en) Process for the manufacture of phosphoric acid
AU2569688A (en) Process for the production of a polypropylene molding composition
AR244351A1 (es) Procedimiento para la obtencion de acido cromico.
AU3544497A (en) Process for the industrial preparation of phosphosal by phosphorilation with phosphorus pentoxide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

ENP Entry into the national phase

Ref document number: 2001 106629

Country of ref document: BG

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 149314

Country of ref document: IL

Ref document number: 518582

Country of ref document: NZ

Ref document number: 200203266

Country of ref document: ZA

Ref document number: 1200200365

Country of ref document: VN

WWE Wipo information: entry into national phase

Ref document number: P20020367A

Country of ref document: HR

Ref document number: 2389173

Country of ref document: CA

Ref document number: IN/PCT/2002/00431/DE

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: PV2002-1502

Country of ref document: CZ

ENP Entry into the national phase

Ref document number: 2001 568401

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 6152002

Country of ref document: SK

WWE Wipo information: entry into national phase

Ref document number: 1020027005739

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: PA/a/2002/004993

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 018030467

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 200200584

Country of ref document: EA

ENP Entry into the national phase

Ref document number: 2001 107088

Country of ref document: BG

Kind code of ref document: A

WWR Wipo information: refused in national office

Ref document number: PV2002-1502

Country of ref document: CZ

ENP Entry into the national phase

Ref document number: 20020643

Country of ref document: UZ

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2001239000

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2001 9053

Country of ref document: AT

Date of ref document: 20010927

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 20019053

Country of ref document: AT

WWP Wipo information: published in national office

Ref document number: 1020027005739

Country of ref document: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase